Inventor · disambiguated record
John S. Debenham
Also filed as: DEBENHAM JOHN · DEBENHAM JOHN S
28 granted patents·5 pending applications·67 citations·filing 2003–2022
93Inventor score
Files withMERCK SHARP & DOHME16MERCK SHARP & DOHME LLC6DEBENHAM JOHN S4CLEMENTS MATTHEW J3MERCK & CO INC2
Top patents by PatentIndex Score
33 records- 0188US7999107B2Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2008·Granted Aug 16, 2011·13 cites·16 claims
- 0283US8372863B2Tetrahydro-1H-pyrrolo fused pyridonesMERCK SHARP & DOHME·Filed 2009·Granted Feb 12, 2013·4 cites·14 claims
- 0383US7271266B2Substituted 2,3-diphenyl pyridinesMERCK & CO INC·Filed 2003·Granted Sep 18, 2007·21 cites·8 claims
- 0481US11028092B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 8, 2021·2 cites·24 claims
- 0581US7091216B2Substituted furo[2,3-b]pyridine derivativesMERCK & CO INC·Filed 2003·Granted Aug 15, 2006·17 cites·14 claims
- 0678US10934294B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Mar 2, 2021·2 cites·13 claims
- 0775US9499534B2Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 22, 2016·1 cites·14 claims
- 0871US8445680B2Tetrahydrothieno pyridinesDEBENHAM JOHN S·Filed 2009·Granted May 21, 2013·2 cites·14 claims
- 0968US7728141B2Substituted naphthyridinone derivativesMERCK SHARP & DOHME·Filed 2004·Granted Jun 1, 2010·4 cites·8 claims
- 1065US12497403B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 16, 2025·0 cites·19 claims
- 1163US8815865B2Substituted 4-hydroxypyrimidine-5-carboxamidesCLEMENTS MATTHEW J·Filed 2010·Granted Aug 26, 2014·1 cites·4 claims
- 1262US11161819B2Substituted tetrahydroisoquinoline compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2020·Granted Nov 2, 2021·0 cites·17 claims
- 1355US12492187B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·11 claims
- 1455US12428397B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 30, 2025·0 cites·13 claims
- 1554US2019161448A1Substituted tetrahydroisoquinoline compounds useful as gpr120 agonistsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1654US2022017526A1Pyrazolopyrimidine pde9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 1753US12344616B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 1, 2025·0 cites·17 claims
- 1851US12304899B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted May 20, 2025·0 cites·13 claims
- 1947US12247031B2Cyclobutyl pyrazolopyrimidine PDE9 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·5 claims
- 2046US8278304B2Substituted 4-hydroxypyrimidine-5-carboxamidesCLEMENTS MATTHEW J·Filed 2009·Granted Oct 2, 2012·0 cites·17 claims
- 2144US2010029697A1Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulatorsDEBENHAM JOHN S·Filed 2008·Application pending·0 cites
- 2244US2010063032A1Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulatorsDEBENHAM JOHN S·Filed 2008·Application pending·0 cites
- 2342US10864211B2Hydroxy isoxazole compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2017·Granted Dec 15, 2020·0 cites·14 claims
- 2442US9708270B2Substituted spiropiperidinyl compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 2541US10143681B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 4, 2018·0 cites·16 claims
- 2641US10000501B2Inhibitors of HIF prolyl hydroxylaseMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·5 claims
- 2740US10875851B2Factor XIIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 29, 2020·0 cites·13 claims
- 2839US2008269279A1Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulatorsCLEMENTS MATTHEW J·Filed 2008·Application pending·0 cites
- 2937US9006268B2Prolylcarboxypeptidase inhibitorsDEBENHAM JOHN S·Filed 2011·Granted Apr 14, 2015·0 cites·9 claims
- 3037US8372857B2Substituted 4-hydroxypyrimidine-5-carboxamidesMERCK SHARP & DOHME·Filed 2010·Granted Feb 12, 2013·0 cites·10 claims
- 3136US10208060B2Inhibitors of HIF prolyl hydroxylaseCAI JIAQIANG·Filed 2015·Granted Feb 19, 2019·0 cites·3 claims
- 3236US10065945B2Isoquinoline derivatives as MGAT2 inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 4, 2018·0 cites·14 claims
- 3336US8669252B2Prolylcarboxypeptidase inhibitorsSHEN DONG-MING·Filed 2011·Granted Mar 11, 2014·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when John S. Debenham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →